Concurrent Tech. - Final Results for the year ended 31 December 2024

Concurrent Technologies

14/04/2025 07:00

RNS Number : 8611E

Concurrent Technologies PLC

14 April 2025

 

14 April 2025

 

 

Concurrent Technologies Plc

(the "Company" or the "Group")

 

Final results for the year ended 31 December 2024

 

Record financial performance, underpinning confidence in long-term growth

 

Concurrent Technologies Plc (AIM: CNC), a designer and manufacturer of leading-edge computer products, systems, and mission-critical solutions used in high-performance markets by some of the world's major OEMs, announces its audited final results for the year ended 31 December 2024.

 

Financial Highlights

 

2024
2023 Restated
% change
Revenue
£40.3m
£31.7m
27%
Gross Profit
£20m
£15.6m
28%
Profit before tax & exceptionals
£5.2m
£3.7m
40%
Earnings per share
5.49p
4.06p
26%
Dividend per share
1.1p
1.0p
10%
EBITDA
£7.8m
£6.0m
30%
Order intake
£41m
£28.2m
45%
Closing cash
£13.7m
£11.1m
23%

 

·
Record financial performance in FY24, delivering revenue of £40.3m, up 27% on the prior year.
·
Profit before tax increased by c.40% to £5.2m, including a significant investment of £1.1m in the Systems business, as planned.
·
Gross profit increased by 28% to £20m (FY23 £15.6m) reflecting the significant increase in revenue with the gross profit margin remaining strong at 49.5% (FY23 48.4%)
·
EBITDA increased by 30% to £7.8m (FY23 £6.0m).
·
Cash generative with closing net cash balance of £13.7m (FY23 £11.1m), despite a one-off exceptional last-time investment in inventory in H1 of $4.6m / £3.5m.
·
The Board will propose, at the Company's Annual General Meeting to be held on 12 June 2025, a final dividend of 1.1 pence per Ordinary Share in the Company (FY23 1.0p). Subject to the approval of shareholders, the final dividend will be paid on 4 July 2025 to shareholders on the register on 20 June 2025.

 

Operational Highlights

·
Continued investment in R&D to improve the cadence and time to market of the Group's products as demonstrated by several new product launches including Rhea, to support existing and new VME customers and Hermod II, highlighting the Group's ambitious product roadmap within the Systems business.
·
New partnerships secured, including with Parry Labs, Eizo Rugged and a fast-growing defence prime contractor in the US, which are critical for the Group to strengthen its position in the defence sector.
·
Launch of new website and update to branding to better reflect the Company's vision and ambitions.
·
The Group now structured and operating across two business units - Products and Systems - to align with growth strategy.

 

Products business unit

·
Secured 22 design wins across key geographies, including 10 'major wins' underpinning the Group's long-term growth trajectory.
·
The design wins include the largest-ever contract to date, with a major US Defence & Aerospace contractor, valued at $6 million, set to contribute materially from 2027.
·
Invested in machinery, test equipment and power infrastructure to enhance manufacturing efficiency.

 

Systems business unit

·
Significant investment in FY24 with performance in line with the Board's expectations and Phillips Aerospace now fully integrated into the non-US Systems business.
·
Early signs of success, driven by a significant $3.7m design win contract with a leading defence platform provider in Asia, a new market for the Systems business unit.
·
Strategic investments in key hires to accelerate growth, including a new Vice President of Systems in LA, and doubling the size of the team in the region.

 

Post-Period End

·
Received a significant £3.4m order for the Company's VME-based 6U computer boards from a long-standing European customer, underscoring the Group's support for the VME standard.
·
Launched Kratos, one of the first and most powerful rugged plug-in card's available today, built on Intel's latest 6516P-B processor which the Company had access to six months early.
·
Commenced trading on the OTCQX® Best Market in the US, in addition to AIM, to better engage with US investors, data distributors and media partners.
·
20-year lease for a new property for Concurrent's Colchester based headquarters and manufacturing capability agree, with planned capacity expansion in US in FY25 to meet the growing demand for the Group's products.

 

Outlook

·
There is growing momentum across the Products and Systems business units, and the Company expects this trend to continue in the coming years.
·
The Group aims to navigate the rapidly evolving tariff arrangements being implemented by the US administration with efficiency and pricing measures, as well as monitoring any impact of longer-term tariffs on the Company's programmes and markets.
·
Board expects trading for the full year to be in line with market expectations.

Miles Adcock, CEO of Concurrent Technologies, commented: "FY24 has been another transformative year for Concurrent in which we delivered a robust financial performance, demonstrating the success of our refreshed strategy. Our focus on delivering industry-leading solutions at pace and investing in both our Products and Systems business units, position us well for long-term growth.

"2025 has started strongly in terms of both output and winning. Notwithstanding the significant uncertainty created by new tariffs, we currently expect to deliver results for FY25 in line with market expectations."

 

Enquiries:

 

Concurrent Technologies Plc
 Miles Adcock - CEO
Kim Garrod - CFO
+44 (0)1206 752626
Alma Strategic Communications
 Hannah Campbell
Josh Royston
Will Merison

 +44 (0)20 3405 0205
Cavendish Capital Markets Limited (NOMAD)
 Neil McDonald
Peter Lynch

 +44 (0)131 220 9771
+44 (0)131 220 9772

 

About Concurrent Technologies Plc

 

Concurrent Technologies Plc develops and manufactures high-end embedded plug-in cards and systems for use in a wide range of high-performance, long-life cycle applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets, including applications within extremely harsh environments. The processor products feature Intel® processors, including the latest generation embedded Intel® Core™ processors, Intel® Xeon® and Intel Atom™ processors. The products are designed to be compliant with industry specifications and support many of today's leading embedded operating systems. The products are sold world-wide.

 

Chair statement   

 

FY24 marked another record year for Concurrent, with exceptional revenue and profit performance, and a strong order book and cash position. This success is driven by our refreshed strategy which focuses on accelerating the time to market of our products. Significant efforts have been made across the Group, including investments in R&D, strengthening Company culture, and optimising the team structures to support our strategy and to position the Company to capitalise on the exciting prospects in FY25 and beyond. 

 

The year in review

 

The Group reported record revenue and profitability for the year of £40.3m and £5.2m respectively, evidencing the transformation of the business and successful growth strategy implementation. The increase in profit reflects the initial delivery of operational gearing as the business scales. This performance is achieved despite considerable investment in the Systems business in LA which was acquired in FY23 and was loss making in FY24, in line with expectations. 

 

The Group secured 10 major design wins in FY24, including our largest contract to date. Alongside this, Concurrent launched several new products demonstrating the increasing appetite for our solutions against the larger players in the industry. We also secured our first major Systems design win in the year, highlighting that the investment being made into the Systems business - including the integration of Phillips Aerospace - is proving successful.

 

This progress, alongside the strength of our statement of financial position, puts us in an opportune position for continued growth.

 

Execution against strategy 

 

We are committed to providing cutting-edge, reliable technology to our customers at an unparalleled pace and, through our Systems and Products units, we have continued to deliver in FY24.

 

The 10 major design wins secured through the Products unit will ramp up in the coming years in line with our customers' programmes, but they provide long-term, multi-year revenue visibility, which supports the investment plans in our R&D roadmap. 

 

The Systems unit, which is still in its early stages, is making solid progress and we are confident this unit will grow going forward. With the integration of Phillips Aerospace, we secured several key contracts and are seeing positive momentum in both the US and international markets.

 

While organic growth remains a priority, as we look to significantly expand Concurrent's UK product manufacturing capacity with a new facility to accommodate growth opportunities, we also see opportunities for bolt-on acquisitions to enhance our Systems capability, as demonstrated so far by the successful acquisition of Phillips Aerospace. 

 

Board and people

 

We were delighted to welcome Issy Urquhart to the Board as an Independent Non-Executive Director in February 2024. Issy brings over 30 years' experience working with global technology and financial services businesses, where she's been responsible for implementing successful people programmes. She is already proving to be an invaluable guide to Concurrent as we deliver on our growth strategy and create the right environment for our people to succeed.

 

In FY24, our CEO, Miles Adcock, played a pivotal role in defining and embedding a new target culture across the organisation, centred on four key pillars: get things done, no spectators, ambition, and buzzing.

 

This culture emphasises a proactive and results-oriented approach, encouraging all employees to actively contribute to the Company's success by sharing ideas, adding value, and embracing ambition. It underscores a commitment to achieving excellence while fostering a positive, inclusive, and dynamic workplace environment. As the organisation continues to expand, this cultural transformation will ensure alignment and cohesion among both new hires and long-standing team members.

 

I would also like to take this opportunity to thank the whole team for their hard work and commitment in what has been another notable year for the Company. 

 

Dividend

 

A 1.1p dividend has been proposed for shareholder approval at the annual general meeting (AGM) which, if passed, will amount to c. £942,000 paid in early July 2025. This reflects a 10% increase on last year and recognises the improved performance, whilst retaining funds for future growth. The Board anticipates this balance will continue, with an appropriate level of cover maintained to enable investment for future growth.

 

Outlook

 

We remain focused on launching leading-edge products and accelerating the ramping up of design wins across both the Boards and Systems units for new and existing customers, converting into significant long-term revenue streams for Concurrent. The performance in FY24 supports this strategy and we are already seeing positive momentum in the new financial year, providing confidence in the positive performance in FY25 and beyond. 

 

Mark Cubitt

Chairman

 

 

CEO statement  

 

Overview  

 

I am very pleased to be reporting on another year of strong growth for Concurrent, in which we delivered on our commitments - executed as planned - and we continue to position the Group to become a much larger business over time.   

 

Financial performance 

 

We delivered a record financial performance across all key metrics in FY24, with revenue of £40.3m, up 27% (FY23: £31.7m), largely driven by our renewed focus on developing sector-leading products, combined with an energised sales team across our home markets that have been instrumental in driving new customers as well as winning new programmes with existing customers. I'm proud that we have delivered record results across the board whilst maintaining strong investments in the areas that we have declared will drive ongoing growth.   

 

Strategy 

 

The Group now operates across two units - Products and Systems - to align with our growth strategy and ambition of being the first to market with the latest technology. We have made good progress throughout the year in ensuring these divisions are set up for growth, incorporating the acquired Phillips Aerospace into Systems and adjusting our leadership teams to reflect this progress and focus. Whilst we are excited by the opportunity to significantly scale Concurrent organically over the next few years, we believe there is also a range of opportunities to expand our capability, customer list and market penetration through acquisition. The acquisition of Phillips Aerospace has been successful and is a good example of how we have delivered on our acquisition strategy to expand the Systems division. Alongside this, the company is now also exploring adjacent and complementary businesses that have the potential to open new opportunities in new markets.

 

Products 

 

Our long-standing Products business designs and manufactures computer boards, and this is where we have substantial expertise and a reputation for quality and collaboration. Much of our business in boards is secured via 'design wins' where customers integrate our products into their programmes, leading to purchase orders in future years as production volumes ramp up, usually two to three years later. This is the most important leading indicator of future growth as a 'major design win' and is one with the potential to achieve peak volumes of >£1m per annum for several consecutive years. Out of 22 design wins, we secured 10 major design wins in FY24, representing a lifetime value to the business of at least £100m. Notably, we secured our largest-ever contract of $6m with a major US defence and aerospace prime contractor, highlighting the potential for future upscaling. This contract was for an initial $4.46m in H1 FY24, with an additional uplift of $1.52m in August, reflecting the customer's trust in the reliability of our products and the strength of the relationship.

 

Doubling the capacity of our facility in Colchester in FY24 has been crucial to supporting the increasing number of design wins and post year end, we signed a 20-year lease for a new property for our Colchester headquarters and manufacturing capability. This new facility will further the Company's ability to service the ongoing growth of the business. We have also invested in our machinery, test equipment and power infrastructure which will further enhance our manufacturing efficiency. 

 

Systems  

 

Our Systems business unit, which is still in its early stages of development, performed as we expected, in line with our strategic plan, and we remain confident that this unit will grow in 2025. Phillips Aerospace is now successfully integrated with our non-US Systems business and we are already seeing excellent progress, driven by a significant $3.7 million order win for Systems in Asia and three new contracts in the US. The successful expansion into this new market is a clear indicator of the growing momentum in our Systems business unit, and we expect this trend to continue in the coming years. 

 

The Systems business is strategically benefitting from careful investment in key hires. We welcomed Michael Harden to the Group, who joined our Executive Committee in FY24 as Vice President of the Systems business in LA, and we have now doubled the number of colleagues operating from LA. 

 

With an FY24 closing backlog of c. $5m, the Systems business is well positioned for growth in FY25, and we are mobilising a strong team accordingly, with a pending move into a new state-of-the-art facility.  

 

Markets 

 

The defence sector remains a key driver of our overall growth, now accounting for 87% of our board revenue.  As global military services work to improve their operational capabilities, the increased focus on defence electronics to upgrade existing platforms is fuelling demand for our products. As mentioned, we are also seeing growth in international geographies, particularly in the USA, where our systems solutions are gaining traction. The Sensor Open Standards Architecture (SOSA) initiative in the US is creating new opportunities for suppliers like us to displace established competitors and we are capitalising on this shift with our innovative products and services. Rising defence budgets worldwide are further driving growth, all of which will translate into longer-term in-field deployments, resulting in step-changes in revenue for Concurrent. Industrial and scientific (7%) and communications and other (6%) are our additional important domains. 

 

R&D 

 

Progressive R&D for new product development remains the priority for organic growth. With continued focus on innovation with launches including Rhea, Magni, TR MDx/6sd-RCR, and Hermod II in FY25, we are developing real momentum with customers - a trend set to continue during 2025.

 

Rhea, part of our expanded VME range, taps into an estimated $300m market. A £3.4m order from a long-standing European customer reinforces our commitment to the VME standard and supporting customers with reliable, backward-compatible solutions. We also launched Magni, a high-performance SOSA-aligned PIC, and TR MDx/6sd-RCR to meet growing demand for compute-intensive solutions.

 

Hermod II, a rugged 10 Gigabit Ethernet switch designed for harsh environments in defence and heavy industrial sectors, adds to our product offerings at the board level, enabling Concurrent to occupy more of a system with our own technology. It highlights the ambitious product roadmap within the Systems business, aiming to both upgrade existing systems and create solutions for next-generation deployments. 

 

Partnerships 

 

As part of our strategy to develop a broader range of products and services, securing and maintaining partnerships is critical for expanding the size and markets available to us. 

 

In FY24, we established several strategic partnerships to strengthen our position in the defence sector. A key collaboration with Parry Labs - a rapidly growing US defence contractor - enabled us to provide SOSA-aligned hardware, allowing Parry Labs to deliver integrated hardware and software solutions. Another partnership with a fast-growing US defence prime contractor secured them as a key customer for our boards and systems while also supplying a critical switch for our systems. Additionally, our partnership with Eizo Rugged incorporated their graphics card products into our comprehensive systems solutions for customers. 

 

People and ESG  

 

The progress we are making at Concurrent is only possible with a relentless focus on talent and culture. In recent years, we have assembled a Board and Executive Committee with experience in transforming businesses and growing sales globally, and our success in FY24 is due to the efforts of this team. This hard work led to the creation of a new brand launched in the year to better reflect the Group's vision and future ambitions.     

 

To continue with our significant transformation to deliver more products faster to market, we are focused on operational excellence and refined governance. With our people at the centre, we have invested our time and energy in making sure that we maintain an inclusive and engaged workforce providing an attractive reward and benefits offering and a developmental place to work.  A continuing key focus area for the Group is delivering quality and safe products to our customers and ensuring this quality through the management of our supply chain. It is also critical that we maintain robust governance across the organisation, building resilience through our extensive control frameworks. As detailed in the ESG Report in our Annual Report, during FY24 we have continued to invest in all these priority areas, as well as continuing to take steps to minimise our operational impact on the environment and building stronger community ties through several charitable efforts across the business. We have also reported our UK operational carbon footprint for the first time this year, in line with the Streamlined Energy and Carbon Reporting regulations. 

 

Summary and outlook  

 

Concurrent is evolving in a way that builds a foundation for long-term growth and expanded market reach. We have delivered both financially and operationally in FY25 as we continue to bring products to market faster for our customers. 

 

I consider that £100m per annum revenue is a meaningful future milestone for this business and given the progress we continue to make, the Board is fully confident in our ability to achieve this. Trading in FY25 has started well, with a focus on continuing to deliver as planned. Looking further ahead, we anticipate continued growth in revenues and profit from 2026, driven by the full impact of our major design wins and increased capacity across our operations. 

 

Miles Adcock

Chief Executive Officer

 

CFO statement  

 

Financial KPIs  

   

2023 (restated)
2024
Revenue
£31.7m
£40.3m
% change vs previous year
73%
27%
Gross profit
£15.6m
£20m
% Gross margin
49.4%
49.5%
Profit before tax
£3.7m
£5.2m
% change vs previous year
658%
40%
Earnings per share
4.06p
5.49p
Dividend per share
1p
1.1p
EBITDA
£6.0m
£7.8m
% change
185%
30%
Closing cash
£11.1m
£13.7m
% change vs previous year
146%
23%
Investment in R&D
£3.8m
£3.0m
Total assets
£46.7m
£50.8m
Shareholders' funds
£34.3m
£38.9m

 

Revenue 

An excellent year with revenues growing by 27% to £40.3m (FY23: £31.7m). The Company generates sales through products and associated services, customer-funded projects (mainly modification programmes), and the sales of Systems and their development. Products sales remain the major revenue contributor at £37m, plus Systems revenue of £2.1m and project revenue of £1.2m.  

 

Geographical split of revenue  

 

Revenue
Year to
Year to
31 December
31 December
2024
2023
£
£
United States
18,333,933
13,060,691
Malaysia
1,782,697
392,850
Germany
3,614,506
6,450,372
United Kingdom
2,929,047
2,148,568
Other Europe
8,146,423
4,178,401
Rest of the World
5,517,477
5,425,434
40,324,083
31,656,316

  

 

The geographical split remains worldwide and is driven by customer requirements (not always the same every year due to the nature of our products). The US remains dominant for revenue growing from 41% to 45% of revenue in FY24 (FY23: £13.1m; FY24 to £18.3m). Europe has increased by c. 10%/£1m, with continued growth in Asia c. 80%/£3m, with a small decrease in ROW.  

The largest customer in FY24 was in the US at £6m, followed by Italy and India. With the direction of working with major primes and increasing our customer base, our top 10 customers equate to c. 54% of our revenue (FY23: 52%)  

 

 

% revenue by top customers 

  

Customer
% of total revenue
1
15%
2
9%
3
5%
4
5%
5
4%
6
4%
7
3%
8
3%
9
3%
10
3%

 

Revenue by market 

  

Defence
£35,016,539
87%
Industrial and scientific
£3,033,160
7%
Medical, communications and other
£2,274,384
6%
£40,324,083


 

Gross profit 

 

Gross profit grew by c. 28% to £20m (FY23: £15.6m), with gross profit margin remaining strong at 49.5% (FY23: 49.4%) The gross margin on products increased marginally in the year. This improvement was largely offset, as expected, by a lower margin mix in our systems and projects businesses which included customer programmes, varying third party content and increased direct manpower costs.  

 

Profit 

 

Profit before tax increased by c. 40% to £5.2m (FY23: £3.7m), after a significant investment in the Systems business of £1.1m, as planned. Product profit margins remain strong at c. 50%, reflecting strong efficiency and effectiveness as a result of investment in people, tools and processes over the last few years. Record revenue for a second year and corresponding increased gross profit have resulted in increased profitability. EBITDA (measured as operating profit adjusted for depreciation and amortisation) increased by 30% to £7.8m (FY23: £6m). Amortisation of our product development was up by 28% to £1.9m, reflecting the new product portfolio continuing to be released into the costs of the business, across the year. Capitalisation of product development is lower in FY24 at £3m (FY23: £3.8m) due to increased customer-funded design and engineering, and the level of internal development.  

 

Earnings per share (EPS) was 5.12p (FY23: 4.06p). This reflects the increased number of shares, in full, following the equity raise in August FY23.  

 

Cost base 

 

The Group continues to balance an efficient and effective cost base, with a strong growth strategy. FY24 represented a first full year of the full investment costs (predominantly people) in the Products business and functions supporting it. In the year, the Group also significantly invested in the Systems business, mainly with additional people to support growth to be ready to efficiently deliver new business as won.  

 

The Group continues to pursue the strategy, investing in R&D, developing new products and securing talented people to deliver and drive the business.  

 

Operating expenses 

 

FY24
£m
FY23
£m
Variance
Total operating expenses
14.8
12.2
2.6
Salaries, NI & pension
11.0
9.0
2.0
Bonus & commissions
1.8
1.9
-0.1
Total salary related costs
12.8
10.9
1.9
Other costs
3.4
3.4
0
Capitalisation
+3.0
+3.8
-0.8
Amortisation
1.9
1.4
-0.5
FX
+0.3
0.3
+0.6
Total
Operating cost of Systems
14.8
1.3
12.2
0.3
2.6
1.0

 

 

As per the table above, a major part of the cost increase has been the investment in people, with salaries increasing by £2m, with an additional £1m accounted for in Systems (full year v partial year of c. 4 months).  

 

Bonus and commissions were slightly down, with increased participants, offset by a £300k one-off charge last year for the change in commission scheme.  

 

Amortisation increased significantly due to our newer products being completed. All other costs are relatively flat, with a favourable swing in foreign exchange rates, important dominated by the USD. 

 

Tax  

 

The Group has undertaken a full tax review and computation, in accordance with UK tax regulations. In FY24 we have a tax charge of £0.5m, due to reduced R&D activity (some of this was diverted to customer-funded projects) and increased profits. Tax planning is an part of our financial efficiency, especially as we grow and the tax regime changes for R&D investment. We will continue to review and maximise our position as we go forward. 

 

Cash flow 

 

The business has a healthy cash balance of £13.7m (FY23 £11.1m), with £7.9m generated from normal operations (a strong increase from FY23 at £5.6m). Revenue was strong in Q4, resulting in high trade receivables at the end of FY24 of £6.2m. The business continued to be cash generative in FY24, despite a significant investment in Systems and a one-off end-of-life purchase on components which although delivered in FY23, was paid for in FY24.  

 

Statement of financial position 

 

Inventory at the close of FY24 was £11m (FY23: £12m). Following investment in inventory during the component crisis of FY22 (and part way through FY23) inventory levels began to normalise through FY24, reflecting increased manufacturing levels and the acceleration of customer deliveries in the year. Going forward we expect inventory levels to continue to normalise but against a larger Group structure. The lead times and availability of components is now back to pre-crisis levels, but we are seeing several examples of reductions in component variations (SKUs), which is leading to some end-of-life products being purchased. This is on a reasonable and manageable level and we will continue to manage it tightly to ensure we maximise efficiency. The business reviews inventory regularly and provides for obsolescence and slow-moving inventory accordingly, which totalled £0.9m in FY24 (FY23 £1.26m). 

 

Inventory continues to be a key factor in enabling the business to deliver most efficiently and effectively, with careful management contributing to the reduction in lead times in getting products to customers. 

 

Trade payables at £5.1m (FY23: £5.7m) are at a slightly lower level to FY23. However, FY24 closing does not now include a large one-off payment for an end-of-life component purchase, which was cleared in April FY24, value c. £3.5m. The lower payables reflect a more effective supply chain and better delivery availability (more efficient in ordering in a timely manner). 

 

Kim Garrod

Chief Financial Officer

 

 

Consolidated statement of comprehensive income 

 

Note
Year to
Year to
31 December
31 December
2024
2023 (as restated)
CONTINUING OPERATIONS
£
£
Revenue
3
40,324,083
31,656,316
Cost of sales
(20,348,752)
(16,018,368)
Gross profit
19,975,331
15,637,948
Administrative expenses
(14,782,064)
(11,951,314)
Group operating profit
4
5,193,267
3,686,634
Finance costs
(93,284)
(86,010)
Finance income
5
79,294
68,145
Exceptional items
28
-
(195,881)
Profit before tax
5,179,277
3,472,888
Tax (charge)/credit
6
(476,839)
(312,752)
Profit for the year
4,702,438
3,160,136
Other comprehensive income
Exchange gains/(losses) on translating foreign operations
(53,556)
(101,340)
Other comprehensive income for the year, net of tax
(53,556)
(101,340)
Total comprehensive income for the year
4,648,882
3,058,796
Profit for the period attributable to:
Equity holders of the parent
4,702,438
3,160,136
Total comprehensive income attributable to:
Equity holders of the parent
4,648,882
3,058,796
Earnings per share
Basic earnings per share
8
5.49p
4.06p
Diluted earnings per share
8
5.18p
3.95p

 

All operations were continuing within the year. 

 

Consolidated statement of financial position 

 

 

31 December
31 December
2024
2023 (as restated)
£
£
ASSETS
Non-current assets
Property, plant and equipment
11
2,686,772
2,465,883
Intangible assets
12
15,392,208
13,914,397
18,078,980
16,380,280
Current assets
Inventories
15
10,875,616
11,958,500
Trade and other receivables
16
8,104,112
6,442,827
Current tax assets
6
14,957
779,621
Cash and cash equivalents
13,706,703
11,118,728
32,701,389
30,299,676
Total assets
50,780,369
46,679,956
LIABILITIES
Non-current liabilities
Deferred tax liabilities
13
2,123,264
1,661,453
Trade and other payables
17
446,477
695,273
Long-term provisions
19
326,596
315,135
2,896,337
2,671,861
Current liabilities
Trade and other payables
17
8,940,768
9,666,412
Short-term provisions
19
18,256
18,256
8,959,024
9,684,668
Total liabilities
11,855,361
12,356,529
Net assets
38,925,008
34,323,428
EQUITY
Capital and reserves
Share capital
21
861,692
861,692
Share premium account
9,950,231
9,950,231
Merger reserve
1,283,457
1,283,457
Capital redemption reserve
256,976
256,976
Cumulative translation reserve
(182,832)
(129,276)
Profit and loss account
26,755,483
22,100,348
Equity attributable to equity holders of the parent
38,925,008
34,323,428
Total equity
38,925,008
34,323,428

 

 

Company statement of financial position

 

31 December
31 December
2024
2023 (as restated)
£
£
ASSETS
Non-current assets
Property, plant and equipment
11
2,468,789
2,374,209
Intangible assets
12
12,788,842
11,217,904
Investments
14
1,947,312
1,572,640
Trade and other receivables
16
3,301,753
-
20,506,697
15,164,753
Current assets
Inventories
15
10,094,952
11,754,564
Trade and other receivables
16
8,980,097
8,534,995
Current tax assets
-
721,921
Cash and cash equivalents
10,692,223
9,111,243
29,767,272
30,122,723
Total assets
50,273,969
45,287,476
LIABILITIES
Non-current liabilities
Deferred tax liabilities
13
1,890,207
1,402,181
Trade and other payables
17
428,913
677,607
Long-term provisions
19
326,596
315,135
2,645,716
2,394,923
Current liabilities
Trade and other payables
17
7,011,848
8,890,046
Current tax liabilities
32,368
-
Short-term provisions
19
18,256
18,256
7,062,472
8,908,302
Total liabilities
9,708,188
11,303,225
Net assets
40,565,781
33,984,251
EQUITY
Capital and reserves
Share capital
21
861,692
861,692
Share premium account
9,950,231
9,950,231
Merger reserve
1,283,457
1,283,457
Capital redemption reserve
256,976
256,976
Profit and loss account
28,213,425
21,631,895
Equity attributable to equity holders of the parent
40,565,781
33,984,251
Total equity
40,565,781
33,984,251

 

 

Consolidated cash flow statement

 

Year to
Year to
31 December
31 December
2024
2023 (as restated)
£
£
Cash flows from operating activities
Profit before tax for the period
5,179,277
3,472,888
Adjustments for:
Finance income
(79,294)
(68,145)
Finance costs
93,284
86,010
Depreciation
673,058
806,236
Amortisation
1,936,561
1,509,167
Impairment loss
4,088
31,557
Share-based payment
744,755
430,854
Exchange differences
25,547
(145,706)
Decrease/(increase) in inventories
1,082,884
(1,868,063)
(Increase)/decrease in trade and other receivables
(1,661,285)
(1,029,033)
(Decrease)/increase in trade and other payables
(749,800)
2,853,322
Cash generated from operations
7,251,074
6,079,087
Tax received/(paid)
641,594
(444,210)
Net cash generated from operating activities
7,892,668
5,634,877
Cash flows from investing activities
Finance income
79,294
68,145
Purchases of property, plant and equipment (PPE)
(877,072)
(495,973)
Payment of acquisition of subsidiary net of cash acquired
-
(685,767)
Capitalisation of development costs and purchases of intangible assets
(3,382,525)
(3,977,839)
Net cash used in investing activities
(4,180,302)
(5,091,434)
Cash flows from financing activities
Equity dividends paid
(856,377)
-
Repayment of leasing liabilities
(233,230)
(215,209)
Interest paid
(93,284)
(86,010)
Issue of ordinary shares
-
6,355,741
Sale/(purchase) of treasury shares
58,500
-
Net cash used in financing activities
(1,124,391)
6,054,522
Effects of exchange rate changes on cash and cash equivalents
-
8,043
Net increase/(decrease) in cash
2,587,975
6,606,008
Cash at beginning of period
11,118,728
4,512,720
Cash at the end of the period
13,706,703
11,118,728

 

Consolidated statement of changes in equity

 

Capital
Cumulative
Profit
Share
Share
redemption
translation
and loss
Total
capital
premium
Merger reserve
reserve
reserve
account
equity
£
£
£
£
£
£
£
Balance at 1 January 2023
739,000
3,699,105
-
256,976
(27,936)
18,509,357
23,176,502
Profit for the period
-
-
-
-
3,160,136
3,160,136
Exchange differences on translating foreign operations
-
-
-
(101,340)
-
(101,340)
Total comprehensive income for the period (restated)
-
-
-
(101,340)
3,160,136
3,058,796
Share-based payment
-
-
-
-
430,854
430,854
Merger reserve
18,077
-
1,283,457
-
-
-
1,301,534
Issue of ordinary shares
104,615
6,251,126
-
-
-
6,355,741
-
Balance at 31 December 2023 (as restated)
861,692
9,950,231
1,283,457
256,976
(129,276)
22,100,347
34,323,427
Balance at 31 December 2023 (reported)
861,692
9,950,231
1,283,457
256,976
(129,276)
22,813,347
35,036,427
Prior year adjustment (note 2)
(713,000)
(713,000)
Balance at 31 December 2023 (as restated)
861,692
9,950,231
1,283,457
256,976
(129,276)
22,100,347
34,323,427
Profit for the period
-
-
-
-
4,702,438
4,702,438
Exchange differences on translating foreign operations
-
-
-
(53,556)
-
(53,556)
Total comprehensive income for the period (restated)
-
-
-
(53,556)
4,702,438
4,648,882
Share-based payment
-
-
-
-
744,755
744,755
Deferred tax on share-based payment
-
-
-
-
5,820
5,820
Dividends paid
-
(856,377)
(856,377)
Sale/purchase of treasury shares
-
-
-
-
58,500
58,500
Balance at 31 December 2024
861,692
9,950,231
1,283,457
256,976
(182,832)
26,755,483
38,925,008

 

 

Company statement of changes in equity

 

Capital
Profit
Share
Share
Merger reserve
redemption
and loss
Total
capital
premium
reserve
account
Equity
£
£
£
£
£
£
Balance at 1 January 2023
739,000
3,699,105
-
256,976
18,022,596
22,717,677
Total profit and comprehensive income for the period
-
-
-
2,919,774
2,919,774
Share-based payment
-
-
-
430,854
430,854
Dividends received
-
-
-
258,670
258,670
Merger reserve
18,077
-
1,283,457
-
-
1,301,534
Issue of ordinary shares
104,615
6,251,126
-
-
6,355,741
Balance at 31 December 2023 (as restated)
861,692
9,950,231
1,283,457
256,976
21,631,894
33,984,250
Balance at 31 December 2023 (reported)
861,692
9,950,231
1,283,457
256,976
22,344,894
34,697,250
Prior year adjustment (note 2)
(713,000)
(713,000)
Balance at 31 December 2023 (as restated)
861,692
9,950,231
1,283,457
256,976
21,631,894
33,984,250
Profit for the period
6,628,833
6,628,833
Share-based payment
-
-
-
744,755
744,755
Deferred tax on share-based payment
-
-
-
5,820
5,820
Dividends paid
-
-
-
(856,377)
(856,377)
Sale/purchase of treasury shares
-
58,500
58,500
Balance at 31 December 2024
861,692
9,950,231
1,283,457
256,976
28,213,425
40,565,781

 

 

 

Notes to the financial statement for the year ended 31 December 2024

 

Note 1
GENERAL INFORMATION
The principal activity of Concurrent Technologies plc ('the Company') and its subsidiaries (together 'the Group') is the design, development, manufacture and marketing of single board computers for system integrators and original equipment manufacturers.
Concurrent Technologies plc is the Group's ultimate Parent Company. It is incorporated and domiciled in the United Kingdom. Concurrent Technologies plc's shares are listed on the Alternative Investment Market of the London Stock Exchange.
The Group's financial statements are presented in pounds sterling (£), which is also the functional currency of the Parent Company. They have been approved for issue by the Board of Directors on 11 April 2025.
Note 2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of preparation
These financial statements are for the year ended 31 December 2024. They have been prepared in accordance with UK-Adopted International Accounting Standards and with the requirements of the Companies Act 2006. These financial statements have been prepared under the historical cost convention.
New and amended IFRS Accounting Standards that are effective for the current year
In the current year, the Group has applied a number of amendments to IFRS Accounting Standards issued by the International Accounting Standards Board (IASB) that are mandatorily effective for an accounting period that begins on or after 1 January 2024. Their adoption has not had any material impact on the disclosures or on the amounts reported in these financial statements.
·
IAS 1: Further amendment to the Classification of Liabilities as Current or Non-Current;
·
IFRS 16: Lease Liability in a Sale and Leaseback;
·
IAS 1: Non-current Liabilities with Covenants; and
·
IAS 7 and IFRS 7: Supplier Finance Arrangements
New and revised IFRS accounting standards in issue but not yet effective
Certain standards, amendments to, and interpretations of, published standards have been published that are mandatory for the Group's accounting years beginning on or after 1 January 2025 or later years and which the Group has decided not to adopt early:
·
IAS 21: Lack of Exchangeability.
None of the above listed changes are anticipated to have a material impact on the Group's financial statements.
Changes in significant accounting policies
There have been no changes in the year to significant accounting policies in the period.
The policies set out below have been consistently applied to all the years presented, except where stated.
Basis of presentation and disclosure exemptions
The consolidated financial statements are presented in accordance with IAS 1 Presentation of Financial Statements. The Group has elected to present the 'Income Statement' and 'Statement of Other Comprehensive Income' in one statement.
The company financial statements are separate financial statements prepared in accordance with FRS 101. The company is a qualifying entity as defined in FRS 101 and has applied the disclosure exemptions available under FRS 101 in the preparation of these financial statements.
As permitted by FRS 101, the company has taken advantage of the following disclosure exemptions:
·
A cash flow statement and related notes (IAS 7)
·
Comparative information in respect of certain disclosures (IAS 1)
·
Disclosure requirements of IFRS 7 (Financial Instruments: Disclosures)
·
Disclosure requirements of IFRS 13 (Fair Value Measurement)
·
Related party disclosures (IAS 24), where transactions are with wholly-owned subsidiaries

 

 

Note 2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

 

Going concern
The Directors have reviewed the approved budget and projections sensitised for different scenarios through to December 2026, considering general and specific market conditions, status of suppliers, liquidity and funding requirements and the needs of subsidiary companies.
The Directors have assessed the viability of the Group using extreme assumptions to reverse stress test the cash forecast. Assumptions include extreme reduction in sales, decrease in gross margin, and reduced reduction in inventory levels (as anticipated in 2025). Additionally, within these scenarios we have excluded any potential beneficial impacts such as tighter management of working capital and cost reduction measures. These have been excluded to retain headroom in the forecast and to provide a worst expected case scenario. The forecast is that significant cash balances remain within the Group and there is no borrowing requirement leaving the Directors confident that the Group will be able to meet its obligations and as such, there is no material uncertainty over the going concern assumption.
Basis of consolidation
The consolidated financial statements incorporate the financial statements of the Company and its subsidiary undertakings. A subsidiary is a company controlled directly by the Group. Control is achieved where the Group has the power over the investee, rights to variable returns and the ability to use the power to affect the investee's returns.
The acquisition method views a business combination from the perspective of the combining entity that is identified as the acquirer. The acquirer recognises the assets acquired and liabilities and contingent liabilities assumed, including those not previously recognised by the acquiree, where recognition criteria are met. Measurement of these items is generally at fair value at acquisition date. The measurement of the acquirer's assets and liabilities is not affected by the transaction, nor are any additional assets or liabilities of the acquirer recognised as a result of the transaction, because they are not the subjects of the transaction. All subsidiaries are 100% wholly owned and are fully controlled by the Group. All intra-Group transactions, balances, income and expenses are eliminated on consolidation.
Revenue recognition
Revenue is recognised by the Group using the five-step process outlined in IFRS 15:
·
Identifying a contract with a customer
·
Identifying the performance obligations
·
Determining the transaction price
·
Allocating the transaction price to the performance obligations
·
Recognising revenue when the performance obligations are satisfied
The Group's principal source of revenue is from the sale of single board computers and associated products (which could include software products which are required by the customer to be added to the boards sold, for example security software). Revenue from the sale of products, including any added software (this is so interlinked with the single board computer (SBC) that they are considered one performance obligation under IFRS 15), is recognised when the Group satisfies its performance obligations by transferring the promised goods to its customers. Control is considered to transfer, at the point in time, when the customer takes undisputed responsibility for the goods. This depends on the terms and conditions of sale with the customer. There are three main terms for delivery: 1) On delivery terms being the Group is responsible for the goods until delivered at the stated delivery address under the contract. 2) Free on Board contract terms means the goods remain the Group's responsibility until they are placed on board the vehicle for shipping, with export duty being the Group's responsibility as well. The customer is responsible after this point. 3) Ex-works contract terms, where the customer is responsible from the point the goods leave the factory or appropriate site, often, under control of the customer's defined shipping arrangement.
The Group provides a basic warranty on its products but does offer customers the opportunity to purchase an extended warranty of one, two or three years for their boards. As the customer has the option of purchasing the additional warranty separately, this is accounted for as a separate performance obligation under IFRS15 where the Group will repair or replace faulty boards at no additional charge to the customer. Contract liabilities on these extended warranties is recognised and released to income over the warranty period until the performance obligation is satisfied. During the 12 months to 31 December 2024, £5,087 was released to Profit and Loss.
Revenue recognised for Systems contracts, under IFRS 15, was £2,132,044 for 2024 accounts. Systems revenue will continue into 2025 and beyond as we are now a Systems company as well. Revenue will normally be recognised over time, in accordance with IFRS 15, using the input method based on the percentage of completion (using costs versus budgeted/forecasts of costs at completion), and will be dependent on the conditions of each specific contract (in line with the five-step process above).

 

Revenue recognition (continued)
For our single board business, invoices are raised on despatch, with payment terms being usually 30 days from date of invoice. For the Systems business, payment terms will be based on negotiations and could include pro-forma and 30-day payment terms but will be subject to negotiated positions.
Cost of sales
Cost of sales consists of external purchases and inventory used on delivering specific contracts, plus the direct manpower (predominantly manufacturing) related to the fulfilment of the specific contracts and direct ancillary costs such as shipping.
Administrative expenses
This includes all non-direct costs (e.g. general overheads such as rent, rates, sales and indirect functions). This also includes non-direct engineering expenses.
Foreign currencies
The functional and presentational currency of the Company is pounds sterling (GBP). Transactions in currencies other than the functional currency of the individual entities within the Group are recorded at the rates of exchange prevailing on the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions and from the remeasurement of monetary items at year end exchange rates are recognised in profit or loss.
In the Group's financial statements, all assets, liabilities and transactions of Group entities with a functional currency other than GBP are translated into pounds sterling upon consolidation. The functional currencies of the entities in the Group have remained unchanged during the reporting period.
On consolidation, assets and liabilities have been translated into GBP at the closing rate at the reporting date. Foreign Exchange differences arising for intercompany transactions are charged within profit and loss. Income and expenses have been translated into GBP at the rates of exchange prevailing on the dates of the transactions over the reporting period. In line with IAS 21, an average rate is used for the period unless exchange rates fluctuate significantly and then the weighted average rate is used. Exchange differences are charged/credited to other comprehensive income and recognised in the cumulative translation reserve in equity. On disposal of a foreign operation the cumulative translation differences recognised in equity are reclassified to profit or loss and recognised as part of the gain or loss on disposal. Goodwill and fair value adjustments arising on the acquisition of a foreign entity are treated as assets and liabilities of the foreign entity and translated into GBP at the closing rate.
Inventories
Inventories are stated at the lower of cost and net realisable value on a first-in first-out basis. Cost includes materials, direct labour and an attributable proportion of manufacturing overheads based on normal levels of activity. Net realisable value represents the estimated selling price after allowing for the costs of realisation and, where appropriate, the cost of conversion from their existing state into a finished condition. Provision is made where necessary for obsolete, slow moving or defective inventories.
Leases
A lease is defined as a contract, or part of a contract, that conveys the right to use an asset (the underlying asset) for a period of time in exchange for consideration. To apply this definition, the Group assesses whether the contract meets three key evaluations which are whether the contract contains an identified asset, which is either explicitly identified in the contract or implicitly specified by being identified at the time the asset is made available to the Group; the Group has the right to obtain substantially all of the economic benefits from use of the identified asset throughout the period of use, considering its rights within the defined scope of the contract; and the Group has the right to direct the use of the identified asset throughout the period of use.
At lease commencement the Group recognises a right of use asset and a lease liability on the statement of financial position. The right of use asset is measured at cost and initial direct costs incurred by the Group. The right of use asset is then depreciated on a straight-line basis over the term of the lease or the estimated useful life of the asset if shorter. At commencement date the Group measures the lease liability at the present value of the future lease payments, discounted using the Group's incremental borrowing rate.
The Group has elected to account for short-term leases and leases of low value assets using the recognition exemptions and payments in relation to these are recognised as an expense in the appropriate period.
Right of use assets have been included in property, plant and equipment and the corresponding lease liability included in trade and other payables. Detailed lease liability information is included in Notes 17 and 20.

 

 

Property, plant and equipment
Property, plant and equipment is stated at original historical cost, net of depreciation and any provision for impairment. Depreciation is charged to write off the cost of assets together with any cost directly attributable with bringing the asset into use, less estimated residual value, on a straight-line basis over their estimated useful lives in accordance with the table below:
Plant and machinery 5-15 years on a straight-line basis
Fixtures, fittings, and equipment 3-7 years on a straight-line basis
Computer equipment 3-5 years on a straight-line basis
Improvements to short leasehold property 5-10 years on a straight-line basis
The gain or loss arising on the disposal or retirement of an asset is determined as the difference between the sales proceeds and the carrying amount of the asset and is recognised in the statement of comprehensive income.
The residual values and useful economic lives of property, plant and equipment are reviewed annually.
Intangible assets
All intangible assets are stated at cost less accumulated amortisation and any accumulated impairment losses.
Goodwill
Goodwill arose upon the acquisition of Phillips Aerospace made on 6 September 2023, which was defined as a single cash generating unit (CGU). The assets acquired are not capable of individually generating revenue on their own, so they are deemed combined within the business as a whole to generate revenue, and therefore the business (Phillips Aerospace) is defined as a single CGU.
The goodwill is the amount attributable to the excess of consideration over the fair value of the net assets acquired, including expected synergies, future growth, critical accreditations, and technical knowledge of the employee, and is recorded in accordance with IFRS 3, 'Business Combinations'.
Goodwill is reviewed and tested annually for impairment.
Research costs
Research costs are charged directly to administrative expense in the statement of comprehensive income as incurred.
Development costs
Development costs are capitalised as intangible assets if the asset can be separately identified; it is in the control of the Group; future economic benefits will accrue to Group; it is technically feasible; the Group has adequate resources to complete the development of the asset; and the costs can be reliably determined.
Capitalised development costs comprise all directly attributable costs necessary to create, produce and prepare the asset to be capable of operating in the manner intended by management, including development-related overheads. Amortisation commences upon completion of the development or when the asset becomes available for commercial production. Capitalised development costs are amortised on a straight-line basis, over the estimated product life which is generally five to seven years. The asset will be reviewed annually for indicators of impairment and whenever indicators suggest that the carrying amount may not be recovered throughout the period in which it is being used, the asset will be subject to a full impairment review. All intangible assets, including those not yet available for use, will be reviewed for indicators of impairment.
All other development costs are recorded under administrative expense in the statement of comprehensive income in the period they are incurred. The following table shows products with a NBV of £500k or more:

 

Product
NBV
Remaining Amortisation Period
Board A
2,509,122
84 months
Board B
1,372,992
84 months
Board C
1,079,818
84 months
Board D
745,697
84 months

 

Customer relationships
Customer relationships were acquired as part of the acquisition of Phillips Aerospace on 6 September 2023 and have applied an income approach valuation using the multi period excess earning method with a useful economic life of 10 years.
Other intangible assets
Intangible assets purchased separately, such as software licences that do not form an integral part of hardware, are capitalised at cost and amortised over their useful lives of three to seven years.
The carrying values of intangible assets with finite lives are reviewed for impairment when events or changes in circumstance indicate the carrying value may be impaired. If any such indication exists, the recoverable amount of the asset is estimated to determine the extent of impairment loss.
The recoverable amount of the asset will be used as for all other intangible assets (e.g. backlog and pipeline opportunities), except where the asset does not generate independent cashflows i.e. additional software packages sold as an add-on to a board.

 

Impairment of property, plant and equipment, and intangible assets
At each statement of financial position date, the Group reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated to determine the extent of the impairment loss.
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows (using both backlog and weighted pipeline) are discounted (10.2% rate used) to their present value. If the recoverable amount of an asset is estimated to be less than its carrying amount, the carrying amount of the asset is reduced to its recoverable amount. An impairment loss is immediately recognised as an expense in the statement of comprehensive income.
Where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset in prior years. A reversal of an impairment loss is recognised as a credit to expenses immediately.
Taxation
Current tax is the tax currently payable based on taxable profit for the year. Current tax for current and prior periods shall, to the extent unpaid, be recognised as a liability. If the amount already paid in respect of current and prior periods exceeds the amount due for those periods, the excess shall be recognised as an asset.
The tax expense for the period comprises current and deferred tax. Tax is recognised in the income statement, except to the extent that it relates to items recognised in other comprehensive income, or directly in equity. In this case, the tax is also recognised in other comprehensive income or directly in equity, respectively.
The Group takes advantage of the Small & Medium Enterprise tax scheme in respect of R&D tax credits. These are included in the taxation line and are accounted for on a receivable basis. This means that the Group applies certain assumptions based on previous R&D claims and any changes to the business and applicable legislation to record a credit through profit or loss and an associated receivable on the statement of financial position in the accounting period in question.
Deferred income taxes are calculated using the liability method on temporary differences. Deferred tax is generally provided on the difference between the carrying amounts of assets and liabilities and their tax bases. However, deferred tax is not provided on the initial recognition of goodwill, nor on the initial recognition of an asset or liability unless the related transaction is a business combination or affects tax or accounting profit. Deferred tax on temporary differences associated with shares in subsidiaries is not provided if reversal of these temporary differences can be controlled by the group and it is probable that reversal will not occur in the foreseeable future. In addition, tax losses available to be carried forward as well as other income tax credits to the Group are assessed for recognition as deferred tax assets.
Deferred tax liabilities are provided in full, with no discounting. Deferred tax assets are recognised to the extent that it is probable that the underlying deductible temporary differences will be able to be offset against future taxable income. Current and deferred tax assets and liabilities are calculated at tax rates that are expected to apply to their respective period of realisation, provided they are enacted or substantively enacted at the year-end date.
Financial instruments
Financial assets and financial liabilities are recognised in the statement of financial position when the Group becomes a party to the contractual provisions of the instrument.
i. Financial Assets
Financial assets are held at amortised cost if the assets are held with the objective to collect contractual cash flows and where the contractual terms of the financial assets give rise to cash flows that are solely payments of principal and interest on the principal amount outstanding. After initial recognition at transaction price being the amount of consideration that is unconditional, receivable balances are measured at amortised cost using the effective interest method, less loss allowance for expected credit losses. The Group's cash and cash equivalents, other financial assets (fixed term deposits), trade and most other receivables fall into this category of financial instruments.
The Group applies the IFRS 9 simplified approach to measuring expected credit losses which uses a lifetime expected loss allowance for all trade receivables.

  

Financial instruments (continued)
i. Financial liabilities
Trade and other payables are not interest bearing and are initially recognised at fair value plus transaction costs directly attributable to their acquisition and then subsequently measured at amortised cost.
ii. Financial liabilities and equity
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. Financial liabilities are obligations to pay cash or other financial assets and are recognised when the Group becomes a party to the contractual provisions of the instrument. They are initially recognised at fair value plus transaction costs directly attributable to their acquisition and subsequently measured at amortised cost using the effective interest method. An equity instrument is any contract that evidences a residual interest in the assets of the Group after deducting all of its liabilities.
Investments in subsidiaries
Investments in subsidiaries, as reported in the Parent Company financial statements, are included at cost less provision for impairment.
Finance income
Finance income comprises interest income accrued on a time basis, by reference to the principal outstanding at the effective interest rate applicable.
Dividends
Dividends to the Company's shareholders are recognised as a liability and deducted from shareholders' equity in the period in which the shareholders' right to receive payment is established.
Employee benefits
Retirement benefits
The Company operates a defined contribution retirement benefit plan. The cost of the defined contribution plan is charged to administrative expenses in the statement of comprehensive income on the basis of contributions payable by the Company during the year.
Share-based payments
The Group issues equity-settled, share-based payments to certain employees. Equity-settled, share-based payments are measured at fair value at the date of grant. In the consolidated Financial Statements, the fair value determined at the grant date of equity-settled, share-based payments is expensed on a straight-line basis over the vesting period based on the Group's estimate of shares which will eventually vest, together with a corresponding increase in equity. In the Financial Statements of the Company, equity-settled, share-based payments issued to employees of the Company are treated in the same manner as in the consolidated Financial Statements. Equity-settled, share-based payments issued to employees of subsidiary undertakings are treated in the Financial Statements of the Company as an increase in investment in subsidiary companies, together with a corresponding increase in equity, over the vesting period based on the Group's estimate of shares which will eventually vest.
Fair value is measured by use of a binomial option pricing model and has been adjusted for the estimated effect of non-transferability, exercise restrictions and behavioural considerations.
For options that have non-market vesting conditions such as EPS growth, the award has been valued using a Black-Scholes Model. This type of model is typically used where no market conditions are associated with the awards.
Options granted from November 2021 have been valued using the Black-Scholes Model. Option pre-November 2021 used the binomial option pricing model.
Treasury shares
The Company's shares which have been purchased and not cancelled are held as treasury shares and deducted from shareholders' equity. No gain or loss is recognised in profit or loss on the purchase, sale, issue or cancellation of the shares.

 

 

Reserves
Share premium accountrepresents the difference between the price received on the sale of shares and their par value.
Capital redemption reservearose from the purchase of shares and represents their nominal value.
Cumulative translation reservearises from the consolidation of foreign subsidiaries.
Share capitalrepresents the nominal value of shares that have been issued.
Profit and loss accountincludes all current and prior period retained profits and share-based payments less treasury shares held at the statement of financial position date.
Merger reserverepresents the difference between the price of the shares issued on acquisition of Phillips Aerospace and their par value.
Provisions
Provisions are recognised when present obligations resulting from a past event will probably lead to an outflow of economic resources from the Group and amounts can be estimated reliably. Provisions reported are for non-purchased warranties (all additional purchased warranties are accounted for under contract liabilities). The obligation under IFRS15 is for the Group to repair or replace faulty boards at no additional charge to the customer.
EPS
DEPS
Basic earnings per share is calculated by dividing the profit attributable to the owners of Concurrent Technologies plc, excluding any costs of servicing equity other than ordinary shares, by the weighted average number of ordinary shares outstanding during the financial year.
Diluted earnings per share is calculated by dividing the profit attributable to the owners of Concurrent Technologies plc, excluding any costs of servicing equity other than ordinary shares, by the weighted average number of ordinary shares and share options outstanding during the financial year.
Key judgements and estimates
Estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectation of future events that are believed to be reasonable under the circumstances.
Estimates
The resulting accounting estimates will, by definition, seldom equal the related actual results. The estimates and assumptions that have a significant risk of creating a material adjustment to the carrying amounts of assets and liabilities are discussed below.
Development costs
To determine whether an impairment is required regarding the carrying value of the capitalised development costs, management have applied the criteria of IAS 36 'Impairment of Assets' and have projected the future economic benefits of the asset. Reviewing against current backlog and estimated weighted, (based on probability factors, predominantly driven by stage of the opportunity), future pipeline opportunities, which will be achieved from this investment using an estimated useful life of seven years. Management considers the review to be sufficiently robust regarding reasonable movements in discount rates (current rate used 10.2%).
A 1% increase in the discount rate would not lead to a material increase in impairment, so therefore, the discount rate is not considered to be the key source of estimation uncertainty, but it is the assumptions made around conversion of future sales that is key to the estimate. Where indicators exist, management then record judgement-based impairment charges which consider project specific technical issues, customer feedback, opportunity for product substitution and other market factors. Estimation uncertainty relates to assumptions about future results.
The Group has performed a sensitivity analysis against our top five boards in terms of NBV, using the key input of gross margin, and the result is the gross margin would have to reduce between 50% and 70%, depending on the board, to achieve a breakeven position. This provides the Directors with comfort in respect of headroom in the impairment calculations.
Inventory
A slow moving inventory provision has been made where necessary where inventory has had no movement in three years or more as per our accounting policy. Items that are provided for, should they start being used again, will have the provision removed/reversed.
R&D Tax Credits
The Group takes advantage of the Small & Medium Enterprise tax scheme in respect of R&D tax credits. These are included in the taxation line and are accounted for on a receivable basis. This means that the Group applies certain assumptions based on previous R&D claims and any changes to the business and applicable legislation to record a credit through profit or loss and an associated receivable on the statement of financial position in the accounting period in question.
Goodwill and intangible assets on acquisition
Application of IFRS 3
During the prior year, the Group acquired Phillips Aerospace and accordingly reviewed the acquisition of the entity in accordance with IFRS 3 'Business Combinations'. Any assets that were identified as being separately identifiable assets have been valued using appropriate valuation techniques in order to determine the fair value of intangible assets acquired as part of the business combination aside from any goodwill arising as a result of the transaction.
These are accordingly recorded as separate intangible assets in Note 12 and have been reviewed for impairment as noted in Note 12.
CGU
The classification of Phillips Aerospace as a single CGU is a key judgement based on the understanding of the elements that were purchased. The assets purchased (e.g., accreditation, customer relationships, working capital etc.) are not capable of generating revenue in their own right, individually, and therefore, they are judged to be intrinsically linked as one to define the business of Phillips Aerospace to be one single CGU. Accordingly, any goodwill arising as a result of this acquisition has been allocated to the CGU identified.
The subsequent impairment and amortisation of the goodwill and assets are based on key estimates and judgements, reviewing the capability of the business from key forecasts of revenue and orders. These are tested for impairment in the same way as development costs (i.e. the use of a discounted cashflow forecast to determine the value in use of the CGU, which has been prepared in accordance with IAS 36).
Capitalisation of development costs IAS 38 - Intangible Assets
Judgement is required when distinguishing the research and development phases of new projects and determining whether the recognition requirements for capitalisation of the development costs are met under IAS 38. Research covers pre-solution options often through feasibility studies of various technologies. Development is the application of research findings or other knowledge to plan or design for the production of new or substantially improved products before the start of commercial production. Development costs are capitalised as an intangible asset if all the following criteria are met: there is technical feasibility of completing the asset so that it will be available for use or sale; the intention is to complete the asset and use or sell it; there is an ability to use or sell the asset; the asset will generate future economic benefits and demonstrate the existence of a market or the usefulness of the asset if it is to be used internally; the availability of adequate technical, financial and other resources to complete the development and to use or sell it; and the ability to measure reliably the expenditure attributable to the intangible asset.
Key judgements and estimates (continued)
Judgements
Judgement is required when distinguishing the research and development phases of new projects and determining whether the recognition requirements for capitalisation of the development costs are met. Research covers pre-solution options often through feasibility studies of various technologies. Development is the application of research findings or other knowledge to plan or design for the production of new or substantially improved products before the start of commercial production. Development costs are capitalised as an intangible asset if all the following criteria are met: there is technical feasibility of completing the asset so that it will be available for use or sale; the intention is to complete the asset and use or sell it; there is an ability to use or sell the asset; the asset will generate future economic benefits and demonstrate the existence of a market or the usefulness of the asset if it is to be used internally; the availability of adequate technical, financial and other resources to complete the development and to use or sell it; and the ability to measure reliably the expenditure attributable to the intangible asset.

 

Prior year restatement 

  

Corporation tax 

A prior year restatement has been included for corporation tax as a result of an erroneous tax asset being included in the 2023 accounts. The impact of this adjustment is to increase the tax charge in 2023 by £713,000 and decrease the corporation tax asset in 2023 by £713,000. 

 

2023 (restated)
2023 as previously stated
Tax (charge)/credit
(312,752)
400,248
Current tax asset
779,621
1,492,621
Profit and loss reserve
22,100,348
22,813,348
Earnings per share
4.06p
4.98p
Diluted earnings per share
3.95p
4.85p
Profit and loss impact
713,000
Cumulative retained earnings impact
713,000


 

  

Note 3
SEGMENT REPORTING

 

The Directors consider that there is only one operating segment, Concurrent Group, which undertakes the design, manufacture and supply of high-end embedded computer products and systems. The Company's products can be supplied to more than one business sector and are sold on a global basis. All manufacturing of computer products is undertaken in the UK.
Whilst looking at sales by business sectors, the Executive Board members of the Company as the Chief Operating Decision Maker do not make decisions regarding allocation of Group resources on such a basis.
The Board in its entirety, i.e. including Non-Executive members, is not involved in making operational decisions. Further, Group profits are not categorised for internal reporting purposes by sectors or geography. The historical and anticipated performance of the Group is therefore reported to the Board of Concurrent Technologies plc as a single entity. Thus, the Directors consider that there are no additional segments required to be disclosed under IFRS 8 - Operating Segments but have provided the following geographic sales analysis. No geographical analysis of non-current assets is provided as non-current assets outside of the UK are immaterial.
During 2024, £5.9m or 15% of Group Revenue depended on a single customer. In 2023, £3.49m or 11.0% of Group Revenue depended on a single customer.
All board revenue is recognised at a point in time, with systems and warranty (immaterial) revenue recognised over time.

 

 

Revenue
Year to
Year to
31 December
31 December
2024
2023
£
£
United States
18,333,933
13,060,691
Malaysia
1,782,697
392,850
Germany
3,614,506
6,450,372
United Kingdom
2,929,047
2,148,568
Other Europe
8,146,423
4,178,401
Rest of the World
5,517,477
5,425,434
40,324,083
31,656,316

 

 

Note 4
GROUP OPERATING PROFIT

 

Year to
31 December 2024
Year to
31 December 2023
£
£
Group operating profit is stated after charging to cost of sales:
Cost of inventories recognised as expense
18,393,779
14,884,586
Staff costs (see Note 10)
2,244,166
1,133,781
Group operating profit is stated after charging/(crediting) to operating expenses:
Net foreign exchange (gains)/losses
(303,144)
279,491
Total expensed research and development costs
2,573,902
1,930,389
Amortisation of intangible assets
1,936,561
1,509,167
Impairment of intangible assets
4,088
31,557
Depreciation of owned property, plant and equipment
468,683
686,403
Depreciation of ROU Asset
204,374
203,870
Staff costs (see Note 10)
10,540,722
9,002,640
Group principal auditor's remuneration:
Audit of Group financial statements pursuant to legislation
158,300
150,000
Other non-auditor remuneration relating to taxation compliance
39,200
25,000

 

 

Note 5
FINANCE INCOME

 

Year to
31 December 2024
Year to
31 December 2023
£
£
Interest earned on bank deposits
79,294
68,145

 

 

Note 6
TAX
Year to
31 December
2024
Year to
31 December
2023 (as restated)
£
£
Current tax expense
-
-
Current deferred tax
1,014,506
401,271
Prior year tax expense
(17,007)
(4,970)
Prior year deferred tax
(520,660)
(113,969)
Current overseas tax charge
-
30,420
476,839
312,752

 

The tax assessed on the Group's profit before tax for the year is less than the standard rate of corporation tax in the UK. The applicable rate of corporation tax for the year to 31 December 2024 was 25.00% (2023: 23.52%). The differences are explained below:

 

Year to
Year to
31 December
31 December
2024
2023 (as restated)
£
£
Profit before tax
5,179,277
3,472,888
Corporation tax on profit before tax at standard rate
1,294,819
816,823
Expenses not deductible for tax purposes
13,771
282,141
UK tax credits
(731,734)
(486,705)
Effect of change in UK tax rate
-
23,747
Share options
4,736
-
Effects of other reliefs
-
-
Difference in overseas effective tax rates
-
(24,150)
Impact of overseas losses
432,914
-
Adjustment in respect of previous years
(537,667)
(299,104)
Tax charge/(credit)
476,839
312,752

 

 

 

Factors that may affect future tax charges are as follows:
UK tax rates, and any changes to R&D tax credits would have an impact on the tax position of the Group and Parent company

 

 

Note 7
DIVIDEND

 

2024
£
2023
£
2024
pence per
share
2023
pence per
share
Final (for the previous year)
856,377
-
1.00
-
Interim
-
-
-
-
856,377
-
1.00
-
Interim dividends are recognised in the Financial Statements in the period they are paid. The Directors have proposed a 1.1p dividend for the year ended 31 December 2024 as a resolution for the Annual General Meeting (total dividend for 2023 was £856,377).

 

 

 

 

Note 8
EARNINGS PER SHARE
Basic earnings per share is calculated by dividing the profit attributable to ordinary equity holders for the period by the weighted average number of Ordinary Shares outstanding during the period. Diluted earnings per share is calculated by adjusting the weighted average number of Ordinary Shares outstanding to assume conversion of all contracted dilutive potential Ordinary Shares. The Company only has one category of dilutive potential Ordinary Share namely the share options.
The inputs to the earnings per share calculation are shown below:


 

 

Year to
31 December
2024
Year to
31 December
2023 (as restated)
£
£
Profit after tax
4,702,438
3,160,136
Year to
31 December
2024
Year to
31 December
2023
No
No
Weighted average number of ordinary shares for basic earnings per share
85,676,344
77,833,759
Adjustment for share options
5,106,393
4,554,202
90,782,737
82,387,961

 

  

Year to
31 December
2024
Year to
31 December
2023 (as restated)
Earnings per share amount
5.49p
4.06p
Diluted earnings per share amount
5.18p
3.95p

 

 

Note 9
DIRECTORS' EMOLUMENTS
Year to
31 December
2024
Year to
31 December
2023
£
£
Fees and emoluments
1,295,912
1,182,172
Pension contributions
16,298
18,632
1,312,210
1,200,804
The emoluments of Directors disclosed above include in respect of the highest paid Director:
Fees and emoluments
614,719
571,029
Pension contributions
-
9,847
The number of Directors to whom retirement benefits are accruing under a defined contribution scheme is:
1
2

 

Detailed information concerning Directors' emoluments, shareholdings and options is provided in the Report of the Remuneration Committee.

 

 

NOTE 10
STAFF COSTS

 

 

STAFF COSTS
Group
Company
Group
Company
Year to
Year to
Year to
Year to
31 December
31 December
31 December
31 December
2024
2024
2023
2023
£
£
£
£
Wages and salaries
10,160,327
7,822,904
8,501,442
7,055,210
Social security costs
1,277,769
985,571
958,837
867,527
Defined contribution pension costs
602,037
547,017
438,431
418,231
Share-based payment
744,755
370,083
430,854
283,761
12,784,888
9,725,575
10,329,564
8,624,729
Average number of employees:
No
No
No
No
Production
40
39
39
38
Other
115
89
103
88
155
128
142
126


 

Direct employment costs capitalised for the year to 31 December 2024 £2,656,170 (2023: £2,389,672).

 

 

Note 11
PROPERTY, PLANT AND EQUIPMENT

 

 

GROUP
Improvements to short leasehold property
Plant, fixtures & computer equipment
Right of use asset
Total
£
£
£
£
COST
At 1 January 2023
784,169
1,497,157
4,405,590
6,686,916
Foreign exchange movement
(6,251)
-
(8,624)
(14,875)
Modification and amendment
-
(234,905)
-
(234,905)
Transfer from intangibles
-
-
75,045
75,045
Additions
227,733
-
523,184
750,917
At 31 December 2023
1,005,651
1,262,252
4,995,195
7,263,098
Foreign exchange movement
(2,018)
(2,785)
(4,803)
Additions
28,629
868,482
897,111
At 31 December 2024
1,032,262
1,262,252
5,860,892
8,155,406
ACCUMULATED DEPRECIATION
At 1 January 2023
260,028
451,828
3,289,953
4,001,809
Foreign exchange movement
(5,193)
1,651
(7,288)
(10,830)
Charge for the year
252,370
203,870
434,033
890,273
Modification and amendment
-
(84,037)
-
(84,037)
At 31 December 2023
507,205
573,312
3,716,698
4,797,215
Foreign exchange movement
(1,067)
533
(1,105)
(1,639)
Charge for the year
121,182
204,374
347,501
673,058
At 31 December 2024
627,320
778,219
4,063,094
5,468,634
NET BOOK VALUE
At 31 December 2023
498,446
688,940
1,278,497
2,465,883
At 31 December 2024
404,942
484,033
1,797,797
2,686,772

 

  

 

COMPANY
Improvements to short leasehold property
Plant, fixtures & computer equipment
Right of use
asset
Total
£
£
£
£
COST
At 1 January 2023
780,351
1,400,165
4,255,588
6,436,104
Transfer from intangibles
75,045
75,045
Modification and amendment
-
(234,905)
-
(234,905)
Additions
60,672
-
303,337
364,009
At 31 December 2023
841,023
1,165,260
4,633,970
6,640,253
Additions
28,629
-
684,704
713,333
At 31 December 2024
869,652
1,165,260
5,318,674
7,353,586
ACCUMULATED DEPRECIATION
At 1 January 2023
256,209
401,478
3,149,917
3,807,604
Charge for the year
94,546
186,393
261,538
542,477
Modification and amendment
-
(84,037)
-
(84,037)
At 31 December 2023
350,755
503,834
3,411,455
4,266,044
Charge for the year
96,452
187,443
334,858
618,753
At 31 December 2024
447,207
691,277
3,746,313
4,884,797
NET BOOK VALUE
At 31 December 2023
490,268
661,426
1,222,515
2,374,209
At 31 December 2024
422,445
473,983
1,572,361
2,468,789

 

 

 

Note 12
INTANGIBLE ASSETS

 

GROUP
Development
Customer
costs
Goodwill
relationships
Other
Total
£
£
£
£
£
COST
At 1 January 2023
31,061,443
1,109,461
32,170,904
Foreign exchange movement
-
(1,106)
(1,106)
Additions
3,939,539
38,300
3,977,839
Additions on acquisition
-
1,230,594
1,130,851
383,593
2,745,038
Transfer between classes
(64,413)
-
-
64,413
-
Transfer to tangibles
(75,046)
-
-
-
(75,046)
At 31 December 2023
34,861,523
1,230,594
1,130,851
1,594,661
38,817,629
Foreign exchange movement
-
19,690
17,513
-
37,203
Additions
3,043,265
-
-
339,260
3,382,525
Adjustment
-
-
-
-
-
At 31 December 2024
37,904,787
1,250,284
1,148,364
1,933,921
42,237,356
AMORTISATION
At 1 January 2023
22,477,838
885,776
23,363,614
Foreign exchange movement
-
(1,106)
(1,106)
Charge for the year
1,349,203
36,248
123,716
1,509,167
Impairment loss
31,557
31,557
At 31 December 2023
23,858,598
-
36,248
1,008,386
24,903,232
Foreign exchange movement
1,268
1,268
Charge for the year
1,685,441
114,895
136,225
1,936,561
Impairment loss
4,088
4,088
At 31 December 2024
25,548,127
-
151,143
1,145, 879
26,845,149
At 31 December 2023
11,002,925
1,230,594
1,094,603
586,275
13,914,397
At 31 December 2024
12,356,661
1,250,284
997,221
788,042
15,392,208

 

 

 

COMPANY
Development
costs
Other
Total
£
£
£
COST
At 1 January 2023
31,061,443
1,109,461
32,170,904
Transfer between classes
(64,413)
64,413
-
Additions
3,939,539
38,300
3,977,839
Transfer to tangibles
(75,046)
-
(75,046)
At 31 December 2023
34,861,523
1,212,174
36,073,697
Additions
3,043,265
321,820
3,365,085
Adjustment
-
5,398
5,398
Disposals
-
-
-
At 31 December 2024
37,904,787
1,539,392
39,444,180
AMORTISATION
At 1 January 2023
22,477,838
885,776
23,363,614
Foreign exchange movement
-
-
-
Charge for the year
1,349,203
111,420
1,460,623
Disposals
-
Impairment loss
31,557
31,557
At 31 December 2023
23,858,598
997,196
24,855,794
Charge for the year
1,685,441
110,015
1,795,456
Disposals
-
Impairment loss
4,088
4,088
At 31 December 2024
25,548,126
1,107,211
26,655,338
At 31 December 2023
11,002,925
214,978
11,217,903
At 31 December 2024
12,356,661
432,181
12,788,842

 

Development costs can be broken down as assets under development (based on original cost) £3,282,211 (2023: £7,428,960) and assets available for use (based on original cost) £34,622,576 (2023: £27,432,563). Transferred in available for use was £nil (2023: £1,088,920).

 

Other intangible assets comprise purchased software used within the business and software licences.

 

All amortisation and impairment charges (or reversals if any) are included within 'Administrative Expenses'.

 

In respect of Intangibles associated with the acquisition of Phillips Aerospace, Concurrent has undertaken an impairment review, with key inputs of revenue growth and costs, using a discount rate of 10.2%. The results of this are that a significant reduction in revenue would have to be incurred to result in any impairment to the assets.   

 

 

Note 13
DEFERRED TAX

 

Share-
Accelerated
based
capital
Tax
payments
allowances
losses
Other
Total
£
£
£
£
£
GROUP
At 1 January 2023
401,945
(2,222,539)
37,799
6,960
(1,775,835)
Credited/(charged) to statement of comprehensive income
88,785
121,376
215,538
-
425,699
Credited/(charged) to equity
-
-
-
(311,317)
(311,317)
At 31 December 2023
490,730
(2,101,163)
253,337
(304,357)
(1,661,453)
Credited/(charged) to statement of comprehensive income
63,848
(978,982)
421,289
26,214
(467,631)
Credited/(charged) to equity
5,820
-
-
-
5,820
At 31 December 2024
560,398
(3,080,145)
674,626
(278,143)
(2,123,264)

 

 

COMPANY
At 1 January 2023
401,945
(2,229,825)
-
-
(1,827,880)
Credited/(charged) to statement of comprehensive income
88,785
121,376
215,538
-
425,699
Credited/(charged) to equity
-
-
-
-
-
At 31 December 2023
490,730
(2,108,449)
215,538
-
(1,402,181)
Credited/(charged) to statement of comprehensive income
63,848
(978,982)
421,289
-
(493,845)
Credited/(charged) to equity
5,820
5,820
At 31 December 2024
560,398
(3,087,431)
- 636,827
-
(1,890,206)

 

 

There has been a reclassification in 2023 of deferred tax asset to show net of the deferred tax liability because all deferred tax assets and liabilities arise in offsettable jurisdictions. As a result, deferred tax assets of £432,642 in 2023 are now presented within the overall net deferred tax liability.  

 

 

Note 14
INVESTMENTS

 

COMPANY
31 December
2024
£
31 December
2023
£
Investment in subsidiary companies
Shares at cost
19,705
19,705
Capital contribution
1,361,656
1,361,656
Equity-settled share-based payment
565,951
191,278
Total investment in subsidiary companies
1,947,312
1,572,639


 

 The Group has closed the Research and Development facility located in India. The investment in the subsidiary company has not been impaired during 2024. This will be impaired in 2025 upon formal dissolution. The investment carried in the accounts is £12,994. 

 

Subsidiary undertakings included in these accounts, which are all wholly owned, at 31 December 2024 are:

 

Place of
Class of
Percentage
Nature
Name
incorporation
share
held
of business
By Company:
Concurrent Tech
Bangalore,
Ordinary
99.999 per cent
Non-trading
India Private Ltd
India
Company
Concurrent
California,
Ordinary
100 per cent
Sale & service of Company products
Technologies Inc.
USA
& R&D services for the Company
By Concurrent Technologies Inc :
Omnibyte
Illinois,
Ordinary
100 per cent
Dormant
Corporation
USA
Phillips Aerospace
California
Ordinary
100 per cent
Developer & manufacturer of industrial
USA
products and associated services


 

Note 15
INVENTORIES

 

Group
31 Dec
2024
Company
31 Dec
2024
Group
31 Dec
2023
Company
31 Dec
2023
£
£
£
£
Raw materials
6,948,808
6,168,144
8,357,855
8,153,919
Work in progress
3,640,455
3,640,455
3,407,901
3,407,901
Finished goods
286,353
286,353
192,744
192,744
10,875,616
10,094,952
11,958,500
11,754,564

 

During 2024 the provision for obsolete and slow-moving inventories has been increased by £74,719 (2023: increased by £543,686). In accordance with IAS2, inventories are measured at the lower of cost and net realisable value.
The inventory balance movement includes a write-off provision which has decreased by £237,384 in the period. This comprises obsolete inventory following an in-depth analysis of the Group's inventory.
In 2024, a total of £18.4m (2023: £14.8m) of inventories was included in the Consolidated Statement of Comprehensive Income as an expense.

 

 

Note 16
TRADE AND OTHER RECEIVABLES

 

Group
Company
Group
Company
2024
2024
2023
2023
£
£
£
£
Current
Trade receivables
6,196,812
2,183,749
5,430,181
2,667,667
Prepayments and accrued income
1,550,741
1,359,050
687,535
577,182
Other debtors
356,559
356,559
325,111
325,111
Loan to subsidiary
-
-
-
2,786,644
Amounts due from subsidiary undertakings
-
5,080,739
-
2,178,391
8,104,112
8,980,097
6,442,827
8,534,995

 

 

Group
Company
Group
Company
2024
2024
2023
2023
£
£
£
£
Non-current
Loan to subsidiary
-
3,301,753
-
-
-
3,301,753
-
-

 

The formal loan agreement for the loan to subsidiary was signed in 2024 and the loan has a repayment date of September 2028. Therefore, the loan balance has been reclassified to non-current receivables. 

 

The group applies the IFRS 9 simplified approach to measuring expected credit losses which uses a lifetime expected loss allowance for all trade receivables. Trade receivables have been grouped based on shared credit risk characteristics. The expected loss rates are based on historic performance, as well as current macroeconomic conditions and experience. The Company has assessed the recoverability of inter-company balances, and deem no issues in terms of credit losses, with all amounts being repayable on demand. There have been no previous write-offs of inter-company balances and there are sufficient cash and other current assets to cover the amount. 

 

ECL Provision Matrix 

31 December 2024
Current
More than
30 days
past due
More than
60 days
past due
More than
90 days
past due
Total
Expected loss rate
-
-
-
0.001%
Gross carrying amount
4,525,345
552,964
741,415
377,088
6,196,812
Lifetime expected credit loss
-
-
-
210
210

 

As a Group we don't have a significant amount of bad debt and, historically, bad debts have been very close to nil due to the recurring nature of orders; our customers pay what is owed, so it is not necessary for us to provide for any balances as bad debt. 

 

 

Group
2024
£
Group
2023
£
At 1 January
210
210
Charged/(credited) to statement of comprehensive income
-
-
At 31 December
210
210


 

 

Group
2024
£
Company
2024
£
Group
2023
£
Company
2023
£
More than 30 days
552,964
398,653
18,712
17,998
More than 60 days
741,415
531,201
128,551
128,448
More than 90 days
377,088
257,731
125,876
125,096
1,671,467
1,187,585
273,139
271,542

  

 

Note 17
TRADE AND OTHER PAYABLES

 

 

Current
Group
2024
£
Company
2024
£
Group
2023
£
Company
2023
£
Trade payables
5,052,348
4,469,106
5,707,674
5,608,259
Contract liabilities
588,213
588,213
1,030,449
1,030,449
Other payables
117,589
102,878
355,549
46,329
Current right of use lease liability
310,182
287,746
294,662
268,472
Other taxes and social security costs
277,102
267,953
207,385
202,605
Accruals
2,595,334
1,295,952
2,070,693
1,733,933
8,940,768
7,011,848
9,666,412
8,890,047

 

Non-Current
Group
2024
£
Company
2024
£
Group
2023
£
Company
2023
£
Right of use liability
446,477
428,913
695,272
677,607
446,477
428,913
695,272
677,607

 

Contract liabilities have been disaggregated from other payables in the current and prior years to provide more detailed information to the reader of the accounts as to the nature of other payables.

  

Contract liabilities
Warranty
End of
End of
Non-
Total
(Group and Company)
life
life
recurring
service
engineering
charge
B/fwd as 1 January 2024
49,244
590,936
584
389,685
1,030,449
Charged/(credited) to profit or loss
Addition
16,724
-
-
-
16,724
Release
(5,087)
(63,605 )
(584)
(389,685)
(458,961)
Closing at 31 December 2024
60,882
527,331
-
-
588,213

 

 

Note 18
FINANCIAL INSTRUMENTS

 

Financial Instruments by category

 

 

Financial assets measured at amortised cost
£
GROUP
2023
Non-current:
-
2023
Current:
Trade and other receivables
5,430,181
Cash and cash equivalents
11,118,728
Total for category
16,548,909
2024
Non-current:
-
2024
Current:
Trade and other receivables
6,196,812
Cash and cash equivalents
13,706,703
Total for category
19,903,515


 

Financial liabilities measured at amortised cost
£
GROUP
2023
Current:
Trade and other payables
8,428,578
2024
Current:
Trade and other payables
8,075,453

 

 

Included in the above is trade payables, other payables, accruals and lease liabilities. All non-current liabilities as displayed in Note 17 relate to lease liabilities which are financial liabilities measured at amortised cost.

 

Note 19
PROVISIONS

  

GROUP AND COMPANY
Dilapidation
£
Product
warranty
£
Carrying amount at 1 January 2024
296,879
36,512
Charged to profit or loss
Increase in provisions
11,461
-
Amount utilised
-
-
Carrying amount at 31 December 2024
308,340
36,512
Provisions have been analysed between current and non-current as follows:
Current
18,256
Non-current
326,596

 

Warranties are provided for based on past experience and on the basis of management's best estimate of the Group's liability under 24-month warranties granted on its hardware products.

 

Dilapidations are provided for on the basis of management's best estimate for both the Colchester and Theale offices. This is recognised over the life of each lease. 

 

 

Note 20
LEASES AND COMMITMENTS

The Group leases properties for its operations in the UK and US and the information is presented below, all leases relate to property. 

 

Changes in liabilities arising from financing activities
Group
2024
£
Company
2024
£
Group
2023
£
Company
2023
£
Opening balance
989,935
946,079
1,460,107
1,391,449
Additions
-
-
-
-
Modifications and amendment
-
-
(265,325)
(265,325)
Payments
(326,514)
(286,410)
(301,219)
(269,641)
Interest
86,166
56,990
103,008
89,596
Foreign exchange
7,072
-
(6,636)
-
Closing balance
756,659
716,659
989,935
946,079
Right of use assets
Group
2024
£
Company
2024
£
Opening balance
688,940
661,426
Additions
-
-
Depreciation
(204,374)
(187,443)
Foreign exchange
(533)
-
Closing balance
484,033
473,983
The right of use in relation to leasehold property are disclosed as PPE (Note 11).
Leases are made up of three properties with the terms as follows: UK office (Colchester) has no remaining break clauses; UK office (Theale) has a break clause of 1st April 2028; US office has an annual automatic one-year extension unless notice is given.
Group
Company
Group
Company
2024
2024
2023
2023
£
£
£
£
Within one year
(365,566)
(325,462)
(357,040)
(325,462)
Within 2-6 years
(453,424)
(453,424)
(757,806)
(739,386)
Add unearned interest
62,331
62,227
124,911
118,769
(756,659)
(716,659)
(989,935)
(946,079)
Non-current Note 17
(446,477)
(428,913)
(695,273)
(677,607)
Current Note 17
(310,182)
(287,746)
(294,662)
(268,472)
(756,659)
(716,659)
(989,935)
(946,079)


 

 

At 31 December 2024 the Group was committed to a short-term lease for the Phillips Aerospace office lease.
The Group has elected not to recognise a lease liability for short-term leases or for leases of low-value assets. Payments made on these leases are expensed on a straight-line basis and the value of these expenses in the year was £198,735.
Amounts recognised in the consolidated statement of comprehensive income.

 

 

Group
2024
£
Group
2023
£
Short-term and low-value lease expense
198,735
49,606
Depreciation charge
204,374
203,870
Interest expense
62,378
103,008


 

 

Amounts recognised in the consolidated statement of cash flows.

 

Group
2024
£
Group
2023
£
Short-term and low-value lease expense
-
-
Payment of lease liabilities
326,514
301,219


 

 

Capital commitments
At the end of the year there were no capital expenditure commitments £nil (2023: £nil).

 

 

Note 21
SHARE CAPITAL

 

31 Dec 2024
£
31 Dec 2023
£
Allotted, issued and fully paid share capital:
Ordinary shares (86,169,236 of 1p each)
861,692
861,692


 

 

At 31 December 2024 the Company held 381,522 ordinary shares (2023: 531,522) with an aggregate nominal value of £3,815 (2023: £5,315) in Treasury.

 

 

Treasury shares
Balance as at 1 January 2024
531,522
Shares sold
(150,000)
Balance as at 31 December 2024
381,522

 

Treasury share movement in year due to exercise of share options of £150,000 which were taken out of treasury shares and moved to ordinary shares. 

 

Note 22
PENSION SCHEME
The Company operates a Group Personal Pension Scheme, which all permanent employees may join. The Scheme, which is a defined contribution scheme, is independent of the Company's finances. The Company's contributions are based on between 5.5% and 10% of members' gross salaries, dependent upon the length of service of the individual. The Company has also chosen Royal London as its workplace pension scheme to meet its employer duties under the Auto Enrolment rules. Contributions to the Royal London scheme are at the minimum rates. The total charge to administrative expenses in the statement of comprehensive income is disclosed in Note 10 Staff Costs. Pension contributions payable to the Schemes at the end of the year were £80,020 (2023: £63,681).


 

 

Note 23
FINANCIAL RISK MANAGEMENT

 

The Group is exposed to various risks in relation to financial instruments. The Group's financial assets and liabilities by category are summarised in Note 18. The main types of risks are market risk, credit risk and liquidity risk. The Group's policy in respect of financial risk management is referred to in the report on Corporate Governance.
The Group does not actively engage in the trading or holding of financial assets for speculative purposes. The most significant financial risks to which the Group is exposed are described below.
Market risk analysis
The Group is exposed to market risk through its use of financial instruments and specifically to currency risk which results from its operating activities.
Foreign currency sensitivity
A number of transactions are conducted by companies in the Group in currencies other than their functional currency which give rise to monetary assets and liabilities denominated in other currencies. The Group's exposure to foreign currency exchange risk is mitigated to a large extent by natural hedging, as assets in currency are matched by liabilities in the same currency. The value of monetary assets and liabilities of the Group and Company not held in functional currencies at the statement of financial position date were as follows:

 

 

Net foreign currency monetary assets/(liabilities)
2024
US dollar
£
2023
US dollar
£
Group
3,050,393
(175,103)


 

2024
US dollar
£
2023
US dollar
£
If sterling had strengthened by 5% against US dollar:
Impact on net Group result and equity for the year
(145,257)
21,312
If sterling had weakened by 5% against US dollar:
Impact on net Group result and equity for the year
160,547
(23,555)


 

Exposures to foreign exchange rates vary during the year depending on the volume of overseas transactions. Nonetheless, the analysis above is considered to be representative of the exposure to currency risk. 

 

Credit risk analysis

Credit risk is the risk that a counterparty fails to discharge an obligation to the Group. The Group is exposed to this risk via from cash and cash equivalents and outstanding receivables.

 

The group applies the IFRS 9 simplified approach to measuring expected credit losses which uses a lifetime expected loss allowance for all trade receivables.

 

To measure the expected credit losses, trade receivables and contract assets have been grouped based on shared credit risk characteristics and the days past due.

 

On that basis, the loss allowance as at 31 December 2024 and 31 December 2023 was determined as follows: 

 

Group

 

 

31 December 2024
Current
More than 30 days past due
More than 60 days past due
More than 90 days past due
Total
Expected loss rate
-
-
-
0.01%
Gross carrying amount
4,525,345
552,964
741,415
377,088
6,196,812
Lifetime expected credit loss
-
-
-
210
210

 

31 December 2023
Current
More than 30 days past due
More than 60 days past due
More than 90 days past due
Total
Expected loss rate
-
-
-
0.01%
Gross carrying amount
5,282,708
18,712
128,551
210
5,430,181
Lifetime expected credit loss
-
-
-
210
210

 

 

The Group loss allowances for trade receivables as at 31 December reconcile to the opening loss allowances as follows:

 

2024
2023
£
£
Opening loss allowance at 1 January
210
210
Loss allowance recognised during the year
-
-
Closing loss allowance at 31 December
210
210

 

 

The credit risk for cash and cash equivalents and fixed-term cash deposits is considered negligible since the counterparties are reputable banks with high-quality external credit ratings.

 

Liquidity risk analysis

 

 

2024
Current
More than 30 days past due
More than 60 days past due
More than 90 days past due
Total
Trade payables
3,083,629
799,658
863,568
305,493
5,052,348
Accruals
2,595,334
2,595,334

 

 

2023
Current
More than 30 days past due
More than 60 days past due
More than 90 days past due
Total
Trade payables
4,747,497
673,864
154,861
131,452
5,707,674
Accruals
2,070,693
2,070,693

Liquidity risk is that the Group might be unable to meet its obligations. The Group manages its liquidity needs by monitoring forecast cash inflows and outflows due in day-to-day business. Liquidity needs are monitored in various time bands, on a week-to-week basis and by monthly forecasting.

 

The Group's objective is to maintain cash to meet its liquidity requirements for the foreseeable future. This objective was met for the reporting periods. Funding for long-term liquidity needs is assessed by the Board on a regular basis.

 

The Group considers expected cash flows from financial assets in assessing and managing liquidity risk, in particular its cash resources and trade receivables. The Group's existing cash resources and trade receivables (see Note 16) exceed the current cash outflow requirements. Cash flows from trade and other receivables are all contractually due within three months. 

 

 

 

Note 24
CAPITAL MANAGEMENT

Capital for the reporting periods under review is summarised as follows:

The Group's objectives when managing capital are:

 

i.
to ensure the Group's ability to continue as a going concern
ii.
to provide an adequate return to shareholders
iii.
to ensure the optimal cost of capital to fund the Group's strategy

 

by pricing products and services commensurately with the level of risk.

 

The Group monitors capital on the basis of the carrying amount of equity less cash and cash equivalents as presented on the face of the Consolidated Statement of financial position.

 

The Group manages the capital structure and makes adjustments to it in the light of changes in economic conditions and the risk characteristics of the underlying assets. In order to maintain or adjust the capital structure, the Group may adjust the amount of dividends paid to shareholders, return capital to shareholders, purchase its own shares to hold in treasury, issue new shares or sell assets. There were no changes in the Group's approach to capital management during the year. Neither the Company nor any of its subsidiaries are subject to externally imposed capital requirements.

 

 

Group
Group
2024
2023
£
£
Total equity
38,925,008
35,036,427
Cash and cash equivalents
(13,706,703)
(11,118,728)
Capital
25,218,304
23,917,699
Total Equity & overall financing
38,925,008
35,036,427
Capital to overall financing ratio
0.65
0.68

 

 

 

Note 25
RELATED PARTY TRANSACTIONS

 

 

Dividends paid to Directors during the year amounted to: - 280
Transactions with Key Management Personnel during the period:
Key Management Personnel are the Company's Board. Key Management Personnel remuneration includes the following expenses:

 

 

Group
2024
£
Group
2023
£
Short-term employee benefits
1,260,912
1,305,205
Post-employment benefits
16,299
18,632
Share-based payment (IFRS 2)
400,553
287,773
1,677,764
1,611,610


 

 

Note 26
SHARE-BASED PAYMENT

 

At the beginning of 2021 the Company operated an Enterprise Management Incentive Share Option Scheme. During 2021, a Long Term Incentive Plan (LTIP) was introduced.
The new Scheme provides for a grant price equal to the nominal value of the Company's shares on the date of grant. Options cannot be vested until three years after grant date and vesting is conditional upon the Group achieving a compound percentage growth of the Group average basic earnings per Ordinary Share, for the complete years commencing 1 January of the year of grant and ending with the year most immediately prior to the vesting of the option. The latest date for exercising options is 10 years after grant date and vesting of options is subject to continued employment with the Group.

 

 

2024
Options
No
2024
Weighted
average
price
pence
2023
Options
No
2023
Weighted
average
price
pence
Outstanding at 1 January
4,544,202
16.15
2,289,797
31.14
Granted
832,816
1.00
2,300,209
1.00
Exercised
(150,000)
39.00
-
-
Forfeited/lapsed
(130,625)
1.00
(35,804)
1.00
Outstanding at 31 December
5,096,393
10.86
4,554,202
16.15
Weighted average share price at date of exercise
166.80
-
-
-
Exercisable at 31 December 2024
Nil
-
Nil
-


 

 

Options outstanding at 31 December 2024 had exercise prices ranging from 1.0 pence to 101.50 pence and a weighted average remaining contractual life of 2.14 years (2023: 2.49 years).
The inputs to the Black-Scholes model for options granted over the period were as follows:

 

 

Grant Date
25 Sep 2024
Share price at grant date
£1.16
Exercise price
£0.01
Dividend yield
2.37%
Risk-free interest rate
3.75%
Volatility
39.20%

 

 

Note 27
ULTIMATE CONTROLLING PARTY

 

The Directors have assessed that there is no ultimate controlling party.

  

Note 28
BUSINESS COMBINATIONS

 

Acquisition in 2023.  

 

Acquisition of Phillips Aerospace 

During the prior year, on 6 September 2023, the Group acquired 100% of the voting shares of Phillips Aerospace Limited, a non-listed company based in the USA and specialising in the development and manufacture of industrial products and associated services, in exchange for the Company's shares and cash. The Group acquired Phillips Aerospace Limited because its strategy was to use the Phillips business and diversify it into actual systems, offering it additionally to the Group's customer base, as well as gaining Phillips' customer relationships. These expansion, growth and export opportunities provide an established presence in North America. 

 

Assets acquired and liabilities assumed 

The fair values of the identifiable assets and liabilities of Phillips Aerospace Limited as at the date of acquisition were: 

Assets:
Fair value recognised on acquisition (£)
Tangible fixed assets
20,032
Working capital
140,560
Cash and cash equivalent
146,610
Borrowings
(667,120)
Deferred tax
(339,875)
Net (liabilities) on acquisition
(699,793)
Separately identifiable intangible assets on acquisition
1,889,624
Goodwill on acquisition
815,602
Total fair value of capital invested
2,005,434

 

The deferred tax liability comprises the tax effect of the accelerated depreciation for tax purposes of tangible and intangible assets. 

 

Separately identifiable intangible assets comprise of customer relationships: £1,436,181 License £487,163, technology know-how £195,625 and assembled workforce £195,625.  

 

The goodwill of £815,602 comprises the value of expected synergies arising from the acquisition and a customer list, which is not separately recognised.        

 

From the date of acquisition, Phillips Aerospace Limited contributed £819,500 of revenue and £201,000 to profit before tax from continuing operations of the Group. 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
FR BXLLFEZLXBBZ